These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
242 related articles for article (PubMed ID: 9059926)
1. Studies of transplantation immunology with major histocompatibility complex knockout mice. Chitilian HV; Auchincloss H J Heart Lung Transplant; 1997 Feb; 16(2):153-9. PubMed ID: 9059926 [TBL] [Abstract][Full Text] [Related]
2. Graft rejection by T cells not restricted by conventional major histocompatibility complex molecules. Dierich A; Chan SH; Benoist C; Mathis D Eur J Immunol; 1993 Oct; 23(10):2725-8. PubMed ID: 8104801 [TBL] [Abstract][Full Text] [Related]
3. NK cells contribute to the skin graft rejection promoted by CD4+ T cells activated through the indirect allorecognition pathway. Ito A; Shimura H; Nitahara A; Tomiyama K; Ito M; Kanekura T; Okumura K; Yagita H; Kawai K Int Immunol; 2008 Oct; 20(10):1343-9. PubMed ID: 18697765 [TBL] [Abstract][Full Text] [Related]
4. Comparison of Abeta(b-/-), H2-DM(-), and CIITA(-/-) in second-set skin allograft rejection. Felix NJ; de Serres S; Meyer AA; Ting JP J Surg Res; 2002 Feb; 102(2):185-92. PubMed ID: 11796017 [TBL] [Abstract][Full Text] [Related]
5. Acute rejection of orthotopic corneal xenografts in mice depends on CD4(+) T cells and self-antigen-presenting cells. Tanaka K; Sonoda K; Streilein JW Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2878-84. PubMed ID: 11687532 [TBL] [Abstract][Full Text] [Related]
6. Mechanism of allorecognition and skin graft rejection in CD28 and CD40 ligand double-deficient mice. Habiro K; Kotani M; Omoto K; Kobayashi S; Tanabe K; Shimmura H; Suzuki K; Hayashi T; Toma H; Abe R Transplantation; 2003 Sep; 76(5):854-8. PubMed ID: 14501867 [TBL] [Abstract][Full Text] [Related]
7. Effects of the major histocompatibility complex loci and T-cell receptor beta-chain repertoire on Theiler's virus-induced demyelinating disease. Kim BS; Mohindru M; Kang B; Kang HS; Palma JP J Neurosci Res; 2005 Sep; 81(6):846-56. PubMed ID: 16049971 [TBL] [Abstract][Full Text] [Related]
8. "Indirect" acute islet allograft destruction in nonobese diabetic mice is independent of donor major histocompatibility complex and requires host B lymphocytes. Kupfer T; Beilke JN; Pham K; Buhrman J; Gill RG Transplant Proc; 2008 Mar; 40(2):462-3. PubMed ID: 18374102 [TBL] [Abstract][Full Text] [Related]
9. CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory. Mortara L; Castellani P; Meazza R; Tosi G; De Lerma Barbaro A; Procopio FA; Comes A; Zardi L; Ferrini S; Accolla RS Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3435-43. PubMed ID: 16740768 [TBL] [Abstract][Full Text] [Related]
10. Immune responsiveness against allogeneic platelet transfusions is determined by the recipient's major histocompatibility complex class II phenotype. Sayeh E; Aslam R; Speck ER; Le-Tien H; Lazarus AH; Freedman J; Semple JW Transfusion; 2004 Nov; 44(11):1572-8. PubMed ID: 15504162 [TBL] [Abstract][Full Text] [Related]
11. Studies of major histocompatibility complex class I/II expression on sequential human heart biopsy specimens after transplantation. Sell KW; Tadros T; Wang YC; Hertzler G; Knopf WD; Murphy DA; Ahmed-Ansari A J Heart Transplant; 1988; 7(6):407-18. PubMed ID: 2463352 [TBL] [Abstract][Full Text] [Related]
12. Role of CD4+ T cells in immunobiology of orthotopic corneal transplants in mice. Yamada J; Kurimoto I; Streilein JW Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2614-21. PubMed ID: 10509657 [TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of donor-specific transfusion in inducing tolerance: role of donor MHC molecules, donor co-stimulatory molecules, and indirect antigen presentation. Kishimoto K; Yuan X; Auchincloss H; Sharpe AH; Mandelbrot DA; Sayegh MH J Am Soc Nephrol; 2004 Sep; 15(9):2423-8. PubMed ID: 15339991 [TBL] [Abstract][Full Text] [Related]
14. Donor antigen-presenting cells are important in the development of obliterative airway disease. Szeto WY; Krasinskas AM; Kreisel D; Popma SH; Rosengard BR J Thorac Cardiovasc Surg; 2000 Dec; 120(6):1070-7. PubMed ID: 11088028 [TBL] [Abstract][Full Text] [Related]
15. Anti-class II antibodies, but not cytotoxic T-lymphocyte antigen 4-immunoglobulin hybrid molecules, prevent rejection of major histocompatibility complex class II-negative myeloma in T-cell receptor-transgenic mice. Dembic Z; Hofgaard PO; Omholt H; Bogen B Scand J Immunol; 2004; 60(1-2):143-52. PubMed ID: 15238083 [TBL] [Abstract][Full Text] [Related]
16. Graft rejection across transgene-encoded MHC class II molecules. Rosay P; Hergueux J; Benoist C; Mathis D C R Acad Sci III; 1994 Jul; 317(7):639-43. PubMed ID: 7882148 [TBL] [Abstract][Full Text] [Related]
17. An improved method for examining the corneal endothelium during graft rejection in the rat. Figueiredo FC; Pendergrast DG; Zhang L; Easty DL; Nicholls SM Exp Eye Res; 1998 Dec; 67(6):625-30. PubMed ID: 9990327 [TBL] [Abstract][Full Text] [Related]
18. A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites. Arancibia-Cárcamo CV; Osawa H; Arnett HA; Háskova Z; George AJ; Ono SJ; Ting JP; Streilein JW Eur J Immunol; 2004 Feb; 34(2):471-80. PubMed ID: 14768052 [TBL] [Abstract][Full Text] [Related]
19. Bidirectional blockade of CD4 and major histocompatibility complex class II molecules: an effective immunosuppressive treatment in the mouse heart transplantation model. Ito H; Hamano K; Fukumoto T; Wood KJ; Esato K J Heart Lung Transplant; 1998 May; 17(5):460-9. PubMed ID: 9628564 [TBL] [Abstract][Full Text] [Related]
20. Function and regulation of MHC class II molecules in T-lymphocytes: of mice and men. Holling TM; Schooten E; van Den Elsen PJ Hum Immunol; 2004 Apr; 65(4):282-90. PubMed ID: 15120183 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]